James Paul Scopa Aligos Therapeutics, Inc. (ALGS) insider trading activity

ALGS Quotes by TradingView

James Paul Scopa is of Aligos Therapeutics, Inc.. Currently has a direct ownership of 183,083 shares of ALGS, which is worth approximately $7.05 Million. The most recent transaction as insider was on Oct 25, 2023, when has been sold 183,083 shares (Common Stock) at a price of $0.76 per share, resulting in proceeds of $139,143. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 183K
0% 3M change
0% 12M change
Total Value Held $7.05 Million

James Paul Scopa Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 25 2023
BUY
Grant, award, or other acquisition
$139,143 $0.76 p/Share
183,083 Added 50.0%
183,083 Common Stock

Also insider at

ADVM
Adverum Biotechnologies, Inc. Healthcare
DICE
DICE Therapeutics, Inc. Healthcare
Director
JPS

James Paul Scopa

South San Francisco, CA

Track Institutional and Insider Activities on ALGS

Follow Aligos Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALGS shares.

Notify only if

Insider Trading

Get notified when an Aligos Therapeutics, Inc. insider buys or sells ALGS shares.

Notify only if

News

Receive news related to Aligos Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ALGS